| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Molecular Oncology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 33612 [W. L., J. C.], and Division of Gynecologic Oncology, University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan 48109 [J. L.]
Tumors without p53 mutation are often resistant to p53 gene therapy. We examined the mechanism using p53-resistant A549 cells and p53-sensitive H1299 cells. We found that p53 delivered by adenovirus is poorly expressed in A549 (ARF-null) cells but efficiently expressed in H1299 cells (ARF-positive). Strong p53 expression and apoptosis can be achieved in A549 cells using a p53 mutant resistant to degradation by MDM2 or by coexpression of ARF. The results suggest that enhanced MDM2 activity attributable to loss of ARF contributes to p53 resistance. Surprisingly, tumor cell lines with MDM2 gene amplification are still deficient for ARF expression, suggesting that MDM2 amplification does not substitute for ARF inactivation during tumor development.
This article has been cited by other articles:
|
|
 |
|
  D. M. Gilkes, Y. Pan, D. Coppola, T. Yeatman, G. W. Reuther, and J. Chen Regulation of MDMX Expression by Mitogenic Signaling Mol. Cell. Biol., March 15, 2008; 28(6): 1999 - 2010. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Murph, J. Hurst-Kennedy, V. Newton, D. N. Brindley, and H. Radhakrishna Lysophosphatidic Acid Decreases the Nuclear Localization and Cellular Abundance of the p53 Tumor Suppressor in A549 Lung Carcinoma Cells Mol. Cancer Res., November 1, 2007; 5(11): 1201 - 1211. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Wang, F. J. Rauscher III, W. D. Cress, and J. Chen Regulation of E2F1 Function by the Nuclear Corepressor KAP1 J. Biol. Chem., October 12, 2007; 282(41): 29902 - 29909. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Brady, N. Vlatkovic, and M. T. Boyd Regulation of p53 and MDM2 Activity by MTBP Mol. Cell. Biol., January 15, 2005; 25(2): 545 - 553. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Enns, K. T. Bogen, J. Wizniak, A. D. Murtha, and M. Weinfeld Low-Dose Radiation Hypersensitivity Is Associated With p53-Dependent Apoptosis Mol. Cancer Res., October 1, 2004; 2(10): 557 - 566. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Pan and J. Chen MDM2 Promotes Ubiquitination and Degradation of MDMX Mol. Cell. Biol., August 1, 2003; 23(15): 5113 - 5121. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Huang, T. Tyler, N. Saadatmandi, C. Lee, P. Borgstrom, and R. A. Gjerset Enhanced Tumor Suppression by a p14ARF/p53 Bicistronic Adenovirus through Increased p53 Protein Translation and Stability Cancer Res., July 1, 2003; 63(13): 3646 - 3653. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. V. Oleinik and S. A. Krupenko Ectopic Expression of 10-Formyltetrahydrofolate Dehydrogenase in A549 Cells Induces G1 Cell Cycle Arrest and Apoptosis Mol. Cancer Res., June 1, 2003; 1(8): 577 - 588. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Pluquet, S. North, A. Bhoumik, K. Dimas, Z.'e. Ronai, and P. Hainaut The Cytoprotective Aminothiol WR1065 Activates p53 through a Non-genotoxic Signaling Pathway Involving c-Jun N-terminal Kinase J. Biol. Chem., March 28, 2003; 278(14): 11879 - 11887. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
